Efficacy and safety of GLP-1 agonists in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
2025 · Naunyn-Schmiedeberg s Archives of Pharmacology · 7 citations
https://doi.org/10.1007/s00210-025-03932-3
M
Mark Messak
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
7
Citations
1
h-index
0
i10-index
Mark Messak is an academic researcher from Helwan University. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Healthcare professionals’ stress and burnout & Resilience and Mental Health. The author has an h-index of 1, co-authored 6 publications.
Papers by this author
worksThe interplay of grit, resilience, and burnout among medical students during exams: a cross-sectional study in Mansoura university, Egypt
2026 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-026-35125-0
α-synuclein monoclonal antibodies in Parkinson's disease: A failed promise or unmet potential?
2026 · Journal of the Neurological Sciences · 0 citations
https://doi.org/10.1016/j.jns.2026.125806
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat